bioMerieux (OTCMKTS:BMXMF) Sees Large Volume Increase – Should You Buy?

bioMerieux (OTCMKTS:BMXMF) shares saw strong trading volume on Friday . 137 shares were traded during trading, an increase of 37% from the previous session’s volume of 100 shares.The stock last traded at $110.00 and had previously closed at $112.57.

Analyst Ratings Changes

Separately, BNP Paribas Exane downgraded shares of bioMerieux to a “neutral” rating in a research note on Wednesday, January 28th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

bioMerieux Stock Down 0.6%

The firm’s 50 day moving average price is $122.08 and its two-hundred day moving average price is $129.38. The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08.

About bioMerieux

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.